蜜桃传媒

 quotes Svetlana Blitshteyn in an article about ivabradine, a drug typically used in heart failure patients that has potential for the future of PoTS, the incidence of which has increased fivefold since the COVID-19 pandemic. “Education of medical students and doctors on autonomic disorders, including PoTS, is still lacking,” Blitshteyn said. As a result, PoTS can often be “misdiagnosed with anxiety, depression, panic disorder, anemia, dehydration and many others, so when a doctor doesn’t know much about PoTS, they are most likely to misdiagnose it,” she added.